glp-1/gip peptide Role of a Dual Glucose-Dependent Insulinotropic (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to Treatment GLP-1 and GIP receptor signaling

In 2024 Wegovy was the first drug approved by the FDA to treat cardiovascular disease in people with obesity

Factors such as food interactions and bioavailability will be different for individuals across a patient population with a broad mix of physical and genetic characteristics

These studies showed (with statistical significance) that after lipedema reduction surgery patients experienced: A significant reduction in pain, sensitivity to touch and discomfort a

You made discoveries

If youve spent years feeling like your brain has a background narrative of constant thoughts about your next meal, what you should eat, what you shouldnt have eaten, how to fix tomorrow, you know that noise is exhausting

Prescription History: Proof that the patient was prescribed and took the GLP-1 medication (Ozempic, Mounjaro, etc.) before the severe symptoms began